Using advances in electronics and software, a team of EU-funded researchers is developing new ways to control upper limb prosthetics. Their goal is to improve and facilitate the everyday lives of amputees.
Your response to a drug depends, in part, on your genetic make-up. An EU-funded project is developing a system to help doctors take into account a patient's genotype when prescribing treatment, for safer and more effective therapy.
After cardiovascular diseases, cancer is the second leading cause of death and morbidity in European countries and is one of the most significant health challenges worldwide. An EU-funded project is developing new tools for diagnosing cancer and for understanding the role of proteins in this and other major diseases.
An EU-funded project is developing software, based on artificial intelligence, that enables robots to more effectively interact with autistic children in human-led therapy sessions, helping to improve their social and communication skills.
European science is missing out on talent as leadership positions remain predominantly occupied by men. To challenge this gender imbalance, an EU-funded project is helping research institutes support female staff in their research career and encouraging work-life balance.
An EU and industry-funded project has developed new patient-centred tools and approaches to help people with chronic obstructive respiratory disease (CODP) get more personalised treatments - a means to boost their activity levels, health and well-being.
Peptidomimetics are small molecules that mimic short natural proteins - peptides - and produce the same effects as their natural counterparts. An EU-funded project is developing peptidomimetics that can alternate between biologically active and inactive forms when exposed to light. The technique could lead to new light-controlled drugs which can be turned off and on when needed to treat cancers and other diseases.
Long-term vision, high-level endorsement and participation, and tailored forms of international scientific collaboration are key to overcoming widespread fragmentation and improving service quality 'and' health outcomes in Latin America. This is the overriding conclusion of an international research team backed by the European Union.
An EU-funded project has developed new approaches to tackling chronic inflammatory diseases. These will be used to create precise and individualised treatment options, potentially leading to faster diagnosis, more effective treatments and even cures.
EU-funded researchers are close to developing a cure for Crigler-Najjar syndrome, an extremely rare, life-threatening liver disease. The groundbreaking research, currently being validated in clinical trials, could also pave the way for the treatment of other genetic disorders.
